PRS29 Cost-Utility Analysis of Fixed Dose Combination (FDC) of Indacaterol Acetate (IND) and Mometasone Furoate (MF) As a Maintenance Treatment of Asthma in Patients not Adequately Controlled with Inhaled Corticosteroids and Inhaled Short Acting beta2-Agonists
Keyword(s):
2015 ◽
Vol 96
◽
pp. 132-142
◽
Keyword(s):
1995 ◽
Vol 16
(1)
◽
pp. 17-40
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):